July 27th, 2010 by admin
Oncologics, lipid regulators, respiratory agents, antidiabetics and anti-ulcerants are the five largest drug classes by sales. But annual sales are only half the story. Which drug classes are booming, and which have plateaued–or even dropped? IMS Health has released top-line industry data revealing the 15 largest drug classes, and we’ve crunched the numbers to take a closer [...]
July 14th, 2010 by admin
Chang Lu and his chemical engineering research group at Virginia Tech have discovered how to “greatly enhance” the delivery of DNA payloads into cells. The description of their work will be featured on the cover of Lab on a Chip, the premier journal for researchers in microfluidics. Lu’s ultimate goal is to apply this technique [...]
July 9th, 2010 by admin
For someone with a severe, incurable lung disorder such as cystic fibrosis or chronic obstructive pulmonary disease, a lung transplant may be the only chance for survival. Unfortunately, it’s often not a very good chance. Matching donor lungs are rare, and many would-be recipients die waiting for the transplants that could save their lives.
July 1st, 2010 by admin
Drugs such as amphetamine-type stimulants and prescription medications are more and more what people are choosing according to the United Nations Drug Report for 2010. The number using such drugs will eventually exceed those using opiates and cocaine. Drug use in developed countries has remained relatively stable says the document. But in developing countries it [...]
June 22nd, 2010 by admin
Researchers at Mount Sinai School of Medicine have for the first time differentiated human stem cells to become heart cells with cardiomyopathy, a condition in which the heart muscle cells are abnormal. The discovery will allow scientists to learn how those heart cells become diseased and from there, they can begin developing drug therapies to [...]
June 21st, 2010 by admin
Patients recovering from congestive heart failure at a New York hospital are being offered a telemonitoring system to help with medication compliance. The data collected from the system generates an e-diary of patient adherence to the prescribed drug regimen, so clinicians and doctors can monitor compliance at the patient or study group level.
June 9th, 2010 by admin
For the first time, human embryonic stem cells have been cultured under chemically controlled conditions without the use of animal substances, which is essential for future clinical uses. The method has been developed by researchers at Karolinska Institutet and is presented in the journal Nature Biotechnology.
May 27th, 2010 by admin
GE Healthcare has entered an alliance with CardioDx to co-develop diagnostic technologies to improve the care and management of patients with cardiovascular disease. Building on the alliance, the GE Healthymagination Fund, a new equity fund that makes investments in highly promising healthcare technology companies, has invested $5 million in CardioDx as part of a Series [...]
May 11th, 2010 by admin
The recently enacted healthcare reform legislation provides up to $1 billion in tax credits and cash grants for life sciences companies with 250 or fewer employees that have made or will make “qualified investments” in “qualifying therapeutic discovery projects” during 2009 and 2010. Credits and grants will be awarded through a competitive application process which [...]
May 5th, 2010 by admin
The unused segments of veins extracted to perform heart bypass operations may be a rich source of stem cells that could be used to treat damaged hearts. They also could point the way to new heart drugs. Scientists say that they derived progenitor cells from veins, multiplied them and then injected them back into mice, [...]